CUV 6.00% $14.58 clinuvel pharmaceuticals limited

Ann: Proposed issue of Securities - CUV, page-2

  1. 9 Posts.
    I cannot see the performance criteria in this statement for the CEO to receive 1,500,000 shares in Nov 2023, current value $30,000,000
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.